Dual combination therapy targeting DR5 and EMMPRIN in pancreatic adenocarcinoma.
about
Selecting Targets for Tumor Imaging: An Overview of Cancer-Associated Membrane ProteinsAntagonistic effects of anti-EMMPRIN antibody when combined with chemotherapy against hypovascular pancreatic cancers.Combination therapy with anti-DR5 antibody and tamoxifen for triple negative breast cancer.Quantitative perfusion- and diffusion-weighted magnetic resonance imaging of gastrointestinal cancers treated with multikinase inhibitors: a pilot study.Genetic and molecular alterations in pancreatic cancer: implications for personalized medicine.Diffusion weighted imaging evaluated the early therapy effect of tamoxifen in an MNU-induced mammary cancer rat modelAntitumor efficacy of α-solanine against pancreatic cancer in vitro and in vivoDynamic contrast enhanced magnetic resonance imaging of an orthotopic pancreatic cancer mouse modelDynamic contrast-enhanced MRI evaluates the early response of human head and neck tumor xenografts following anti-EMMPRIN therapy with cisplatin or irradiation.SPARC-Independent Delivery of Nab-Paclitaxel without Depleting Tumor Stroma in Patient-Derived Pancreatic Cancer XenograftsHAb18G/CD147 promotes pSTAT3-mediated pancreatic cancer development via CD44s.Multispectral imaging: a review of its technical aspects and applications in anatomic pathology.A Novel Imaging Biomarker Extracted from Fluorescence Microscopic Imaging of TRA-8/DR5 Oligomers Predicts TRA-8 Therapeutic Efficacy in Breast and Pancreatic Cancer Mouse Models.
P2860
Q28077999-4DCA6988-8F9B-4359-BBB8-3C1584AAF7ADQ33775762-D3AE70D8-1C0A-4DFF-A543-21B86F1C470AQ33989940-E72B567D-470A-45F0-8390-A5C24499DAEEQ34229404-97CC0738-AA53-4A8A-BFA7-3F24F3798762Q34657038-5EB4A5D4-C974-485A-B6B5-0561041B25D9Q34735514-934DCD67-4FE2-481D-A64C-F3CDDF90F9ACQ35088276-00455225-359E-4E78-969E-743A6F7170C0Q35970722-0C7E3FA8-7519-4C62-B85C-CC6E0FCA0085Q35984544-9DF5244E-536B-4078-96A8-A2C0C3369B20Q36917864-BB8169C8-4E1D-40D4-A585-2AE4356EE7E9Q37416242-82AE776C-2741-4E22-AB2E-AEE2C7799323Q38152999-58B384AF-1324-442F-8F18-7CA1C61E95D2Q38820739-1F98AAAC-74B7-415B-8243-3C34498DA9D7
P2860
Dual combination therapy targeting DR5 and EMMPRIN in pancreatic adenocarcinoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Dual combination therapy targeting DR5 and EMMPRIN in pancreatic adenocarcinoma.
@ast
Dual combination therapy targeting DR5 and EMMPRIN in pancreatic adenocarcinoma.
@en
type
label
Dual combination therapy targeting DR5 and EMMPRIN in pancreatic adenocarcinoma.
@ast
Dual combination therapy targeting DR5 and EMMPRIN in pancreatic adenocarcinoma.
@en
prefLabel
Dual combination therapy targeting DR5 and EMMPRIN in pancreatic adenocarcinoma.
@ast
Dual combination therapy targeting DR5 and EMMPRIN in pancreatic adenocarcinoma.
@en
P2093
P2860
P1476
Dual combination therapy targeting DR5 and EMMPRIN in pancreatic adenocarcinoma.
@en
P2093
Cecil R Stockard
Christopher J Rigell
Guihua Zhai
Heidi R Umphrey
Hyunki Kim
Kurt R Zinn
Naomi S Fineberg
Samir Rana
Sharon L Samuel
P2860
P304
P356
10.1158/1535-7163.MCT-11-0581
P577
2011-12-27T00:00:00Z